The endocrine manifestations are unique for each hormone oversecretion-tumor: gastrin oversecretion, leading to Zollinger-Ellison syndrome (ZES), can be readily controlled using proton-pump inhibitors (PPIs) while insulin oversecretion leading to hypoglycemia episodes might be more challenging to control. This evidence concerns the gene INS and Zollinger-Ellison syndrome.